I’ve been looking into the numbers behind some Chinese companies that I think show strong potential for massive returns in the next few years.

A select few include:
$TIGR https://abs.twimg.com/emoji/v2/... draggable="false" alt="🏦" title="Bank" aria-label="Emoji: Bank">
$QFIN https://abs.twimg.com/emoji/v2/... draggable="false" alt="💴" title="Banknote mit Yen-Zeichen" aria-label="Emoji: Banknote mit Yen-Zeichen">
$YI https://abs.twimg.com/emoji/v2/... draggable="false" alt="🏥" title="Krankenhaus" aria-label="Emoji: Krankenhaus">
$FUTU https://abs.twimg.com/emoji/v2/... draggable="false" alt="🏦" title="Bank" aria-label="Emoji: Bank">

Thread https://abs.twimg.com/emoji/v2/... draggable="false" alt="🧵" title="Thread" aria-label="Emoji: Thread">https://abs.twimg.com/emoji/v2/... draggable="false" alt="⬇️" title="Pfeil nach unten" aria-label="Emoji: Pfeil nach unten">

The main data this thread will focus on is revenue growth, user/customer acquisition, volume growth (when applicable), and operating efficiency.

For companies still in their growth stages, I believe these data points more directly indicate strong stock growth.

Now, let’s begin!

UP Fintech Holdings — $TIGR

$TIGR is a brokerage headquartered in Beijing, operating predominantly in SE Asia.

They operate through their online brokerage, wealth management system, IPO distribution (listed $LI $XPEV among others), and ESOP system.

360 DigiTech — $QFIN

$QFIN operates digital consumer finance platforms.

They provide banking & micro-lending solutions, and parter with financial institutions which use their AI driven, best-in-class risk management solutions.

Large TAM, potentially reaching $1.85T USD.

111, Inc — $YI

$YI is a digital healthcare platform, based in Shanghai.

— 1 Drugstore (online pharmacy) provides consumers access to pharma products
— 1 Clinic (online hospital) offers healthcare services
— 1 Drug Mall (online wholesale) serves products direct to pharmacies

Futu Holdings — $FUTU

$FUTU is an online brokerage, headquartered in Hong Kong and operating in SE Asia.

They primarily earn revenue through trade commissions, wealth management interest, and IPO/ESOP fees and services.

This thread barely scratched the surface on these companies and their potential, with many important details being left out to focus on the numbers.

If there is enough interest, I may dive deeper into $QFIN and $YI, and would post my findings here.

In the meantime, feel free to check out the brief analysis I did on $FUTU and $TIGR earlier this month.

Since the post below, $FUTU is relatively even, while $TIGR is up approximately 25%.

Check them out! https://abs.twimg.com/emoji/v2/... draggable="false" alt="⬇️" title="Pfeil nach unten" aria-label="Emoji: Pfeil nach unten"> https://twitter.com/longleverage/status/1379453281370578945">https://twitter.com/longlever...

Here’s where I mention some of the people who inspired me to dig further into these companies.

Unsurprisingly, all these individuals are also fantastic follows on Twitter! https://abs.twimg.com/emoji/v2/... draggable="false" alt="🍻" title="Anstoßende Bierkrüge" aria-label="Emoji: Anstoßende Bierkrüge">

Thanks,
@JonahLupton
@PatternProfits
@LuoshengPeng
@prasadmaddali20
@thetradejourney
@WOLF_Financial